Purpose: Since immunohistological investigations have given rise to divergent perspectives about continued hippocampal neurogenesis in adult humans, a comprehensive transcriptomic analysis of the neurogenesis signature markers supplemented with insights from gliogenesis and apoptotic markers (in context to the developmental stages across age) may discern important aspects and may well be the appropriate methodology for resolving this conflict.
Introduction
Continued adult hippocampal neurogenesis (AHN) in humans was recently questioned (1, 2) .
Studies with contrasting evidence have emerged since then which ranged from absolute denial (3) (4) (5) to approval for the persistence of AHN even in old individuals (6) (7) (8) . In adult mammals (including human) neurogenesis is thought to persist in the subgranular zone (SGZ) of the dentate gyrus (DG) region of the hippocampus (9) . Newly formed neurons from the SGZ travel to hippocampal and prefrontal cortex (10) , and integrate into the existing circuitries (10, 11) .
Induced adult hippocampal neurogenesis was shown to improve spatial memory and performance at the learning tasks (12) in addition to be protective role against neuropsychiatric disorders which presumably precipitate a decline of these functions (12, 13) .
With the accumulation of optimistic evidence, AHN in most of the mammals (including humans) grew into a dogma (1, 14, 15) . Dissenting results regarding AHN in any higher order mammal was rare (16) ; though in recent years, a few studies have denied AHN in human (1) . Dennis et al, 2016 denied AHN in humans using immunohistological methods in postmortem samples across different age groups (4) . The most robust disapproval, however, has appeared recently from Sorrells et al (3) , and it has been followed by a similar denial from Cipriani et al (5) , who based their conclusions on a more comprehensive use of immunohistological and ultrastructural methods, and in a greater diversity of samples. All three AHN negative studies shared the view that if any newly formed cells in the neurogenic niche are found, those are actually glial cells. The denial, nevertheless, was not long lived as AHN in humans was reaffirmed by studies and arguments from Boldrini et al (6) . These investigators used similar immunohistological methods as were emplyed by Dennis group and Cipriani group., The Boldrini group supplemented their methodology by use of additional techniques thus employing a more convincing method of cell counting-unbiased stereology, measured accompanied vasculogenesis, and ensured that studied subjects didn't suffer from any confounding disease before death (17) .
More recently, more robust evidence emerged for AHN in humans (7, 8) . Moreno-Jiménez et al, 2019 using tightly controlled conditions and state-of-the-art tissue processing methods, identified thousands of immature neurons, exhibiting variable degrees of maturation along differentiation stages, in DG of the neurologically healthy human subjects up to the ninth decade of life. They additionally found that continued neurogenesis was reduced in DG of Alzheimer's patients (8) . Tobin et al, 2019 found AHN to persistent through the tenth decade of life and being detectable in patients with mild cognitive impairments and Alzheimer's disease.
These researchers found a reduction of AHN in mild cognitive impairments, and higher AHN associated with better cognitive status (8) .
Hippocampal neurogenesis is believed to be a unique advancement in mammalian evolution though a protracted postnatal neurogenesis has been undoubtedly established in most of the studied mammalian species, with a few exceptions (18, 19) . JS Snyder, 2019, by drawing upon the published data on hippocampal neurogenesis across life span in most commonly studied mammals, observed that a lower rate of neurogenesis with accelerated neurodevelopmental timing is aligned across species (including humans) (20) . New-born neurons during the protracted neurogenesis retain unique plastic properties for long intervals, and have distinct functions depending on when in the lifespan they were born (20) . Based on these confirmations and arguments, continued formation of new neurons seems essential to accommodate new memories and provide adaptive flexibility to new life experience, hence present a survival benefit (20) . A comprehensive review of the literature suggests that studies contesting for AHN in human stand in an arbitrary zone where even a minor difference of the investigatory methods and study designs may lead to alternative interpretations. Neurogenesis involves multiple developmental stages which are characterized by expression of specific protein markers which can be immunostained to observe the lineage specific cells in the neurogenic niche (21) . Until now, these markers were mostly studied, in varying combinations by immunohistological methods within limited age groups, and (most importantly) their comprehensive transcriptomic analysis was largely ignored. A transcriptomic analysis of the differential expression patterns of neurogenesis signature markers, added with the gliogenesis and apoptotic markers (respective to the stages of neuronal maturation in developing to adult age hippocampus) may show or construct the much needed larger picture. It may also resolve the apparent divergence in the interpretations from immunohistological studies. Though this method cannot provide an accurate quantitative estimate of the newly formed neurons (or glial cells), it can distinctively show the trends for the expression of the marker genes in advancing age groups, which can be inferred for the perpetuation of AHN. With all this background, we analyzed the developmental transcriptome (prenatal to adult age) in human hippocampus to check the differential expression of the neurogenesis signature genes (and also gliogenesis and apoptotic markers) respective to the neuronal developmental stages to identify potential answers to the question of AHN.
Materials and Methods
RNA expression data for the neurogenesis signature genes in post-mortem human brain tissue of the Prenatal (n=15), Infant-early childhood (up to 3 years age, n= 5), Adolescence (11-19 years, n= 4), and Adulthood (20-40 years, n=6) ages from the hippocampus were downloaded from development transcriptome database of Allen Brain Atlas (http://www.brainspan.org/rnaseq).
Post-mortem brain specimens only from neurologically healthy individuals and free of significant genetic errors were considered for original data retrieval (to ensure consistency between samples and to decrease potential variation arising of ante-and postmortem conditions, specific selection criteria were followed, details for which, along with the protocols for the laboratory procedures and techniques used, can be found on Allen Brain Atlas website link:
http://help.brainmap.org/display/devhumanbrain/Documentation?preview=/3506181/6651924/Tr anscriptome_Profiling.pdf ).
Gene expression data was categorized as per age groups and median expression values were computed for the targeted neurogenesis signature genes ( Table 1 presents the list of the neurogenesis stage specific signature genes selected for this study). In addition to neurogenesis signature genes, gliogenesis (OLIG 2, VIMENTIN, and S100B), and apoptotic marker genes (BAX and TP53) were also studied. Differential gene expression respective to the neurogenesis maturation stages across the studied age groups (Table1) was analyzed using statistical tests (differences in the median values with standard deviations). We used non-parametric statistical tests (owing to the unequal number of samples in each category). Kruskal-Wallis (KW) (equivalent of parametric One-way ANOVA) and Mann-Whitney U (MWU) tests were used to check if variations existed between all four age groups, and between any two age groups, respectively (Table S1&2 ). For both the statistical tests, the confidence level of 95% (p value <= 0.05) was used.
A post-hoc 'Bonferroni Correction' was applied to check errors caused due to multiple comparisons performed for same sample in MWU test. Box plots with median values and full range of subjective data (were plotted to get trends for the age group specific gene expression ( Fig.1-7 , S1-7). 
Results
(Table S1&2, Figure 1 -7, S1-7)
Neurogenesis signature markers (Stage 1-5)
A prenatal to infant/early childhood sharp decrease in expressions of stem cell, proliferation, immature granule cell, and post mitotic early maturation, was noted with few exceptions (BLBP, GFAP, SOX2, PSA NCAM, CALB2, MAP2, CALB1, NEUN, all showing no significant differences) ( Fig. 1-5 ). BLBP, and SOX2 (stage 1) didn't show significant prenatal to infant/early childhood decline ( Fig. 1, S1 ). GFAP (stage 1) showed insignificant increase between prenatal to infant/early childhood ( Fig. 1 , S1 (c.1)). A post infant/early childhood continued decreasing trend across further age groups in expression occurred for the markers for stem cells (NESTIN, SOX1, SOX4)-Stage 1 (Fig. 1 ), and progenitor cells (KI67, TBR2, MCM2, PAX6)-Stage 2 (Fig. 2) . GFAP, BLBP, and SOX2 (Stage 1) showed the lesser fall (no significant decline) in postnatal expression in comparison to other stem cell marker genes. BLBP showed significant decline only when prenatal expression was compared to adult ( Fig. 1 , S1 (b.2)). SOX2 showed significant decline only when prenatal expression compared to adolescence and adult age group ( Fig. 1 , S1 (e.2, 3)). Uniquely, the postnatal sharp downregulation of KI67 and TBR2 continued across advancing age groups, reached near baseline until adolescent age (Fig. 2) . DCX expression showed an increase in level of significance between infant/early childhood to adulthood group (when compared with prenatal values) ( Fig. S3 (b.1, 3) ). A prenatal to infant/early childhood no difference (though insignificant, the trend of increase for NEUN and CALB1 and in opposite the decreasing trend is observed for MAP2) and thereafter maintained expression of the post mitotic late maturation markers (MAP2, CALB1, NEUN) was noted, Stage 5 (Fig. 5 ). Uniquely, NEUN showed gain in significance, i.e., increase in its expression is noted in adulthood compared to the prenatal age group. Fig S5 (c.3) ). Amongst stage 1-5, no markers showed any significant change in expression among postnatal age groups except, SOX4 (Stage 1) which showed significant decline between infant/early childhood and adult age ( Fig. S1 (f.5) ). There existed no significant differences in the expression across age groups (all MWU comparisons) for GFAP (Stage 1), PSA-NCAM (Stage 3) CALB2
(Stage 4), and CALB1, MAP2 (Stage 5).
Gliogenesis markers
OLIG 2 and VIMENTIN showed significant decline in their gene expression from prenatal to postnatal transition, S100beta (S100B) showed significant increase (~3 folds) during this transition ( Fig. 6, S6 , Table S1&2 ). All the gliogenesis markers showed no significant differences in expression between the postnatal age groups, though trend of curve declined from infant/early childhood to adult with increase in level of significance (when compared to prenatal values) ( Fig. S6 ).
Figure 6
Box plot presentation of Gliogenesis gene expression scores (Statistical significance tested using Kruskal Wallis test, p values: *≤0.05, **≤0.01, ***≤0.001, ****≤0.0001).
Apoptotic markers
BAX and TP53 showed significant decline in expression between prenatal to infant/early childhood (Fig. 7&S7) . For both the markers declining trend continued across age groups with no statistically significant differences for comparisons between close groups (Fig. 7&S7 ). 
Discussion
Study of the hippocampal developmental transcriptome gives a glimpse of the events happening in the neurogenic niche. We studied hippocampal developmental transcriptome in chronological detail and looked for the stage specific expression of neurogenesis signature, gliogenesis, and apoptotic markers. This led to imperative observations which may pave way for future studies to resolve the intense controversy surrounding AHN.
Our results (Table S1&2 , Fig. 1-7 , S1-7) showed that there are contrasting differences in the expressions of the stage specific hippocampal neurogenesis markers when we compare the A postnatal sharp fall in the expression of most of the stem cell markers (NESTIN, SOX1, and SOX4) (Fig. 1) , and thereafter decreasing trend is indicative of a considerable postnatal downfall in production of NSCs. A prenatal-to-childhood sharp decrease in the NSCs has been a common observation in the human developmental studies (3-6). Boldrini et al., noted a decrease of NSCs with aging in age group 14-79 year. Our data showed a trend that, a post childhood decline is very slow, and near maintained between adolescent and adult age groups. GFAP, BLBP and SOX 2 showed a relatively lesser downregulation (only childhood to adolescence: SOX2, and only adolescence to adult: BLBP showed significant decline, no significant difference from prenatal to adult is noted for GFAP) in comparison to the other stem cell markers, this could be explained by the fact that other than NSCs, they also express in glial lineage cells in adult brain.
A post childhood near maintained expression of immature granule cell markers (DCX, PSA NCAM, NEUROD1 didn't show a significant difference between age groups)-Stage 3 ( Fig. 3) , and maintained expression of the post mitotic early maturation markers (SEMA3C, STMN2, TUBB3, CALB2: Calretinin is a calcium binding molecule, which is expressed up to 2-3 weeks in newly born neurons)-Stage 4 ( Fig. 4) , hint for the continued formation of neuronal lineage cells and their further differentiation into immature and early mature neurons.
The expression patterns (post childhood maintained or increased insignificantly between two terminal age groups) of the post mitotic marker genes (Stage 5) ( Sorrels et al, who studied both prenatal and adult age group showed 1600 ± 800/mm 2 of DG in prental brain, with steeply decresing trend in postnatal age groups, almost nil in adult age (3).
Though, the tissue fixation and processing methods Sorrels et al used, might have caused low show of neuronal lineage cells across all ages in their study, as was also suggested by Moreno-Jiménez et al, 2019, who used improvised immunohistological methods (7) . A study in prenatalto-adult age group using tightly controlled conditions and state-of-the-art tissue processing methods, as has been suggested by Moreno-Jiménez et al (7) , may bring some more clarity on age group specific formation of new neurons.
Uniquely, a continued postnatal decrease in apoptotic markers (BAX, and TP53) with insignificant differences between advancing age groups, gives clear indications that there is no increased cell death among the advancing age groups hence total number of the mature neurons may be maintained with aging as was claimed by Boldrini et al (for 14-79 year age group) (6) .
Surprisingly, apoptotic markers were scarcely examined in any histological study in this regard.
A maintained total number of hippocampal neurons further hints for a minimal but continued neurogenesis which would be just sufficient to replenish the average loss of neurons with aging.
A minimal but continued neurogenesis in adult human hippocampus is plausible in view of the available studies which support the presence of stem cell pool in the neurogenic niche which can be engaged in the maintenance of total number of neurons (6, 22) .
In contrast to the neuron lineage cell markers, expression patterns of the gliogenesis markers-VIMENTIN (a pan astrocytic marker), S100B (a post mitotic astrocytic marker), and OLIG 2 (an oligodenderocyte lineage marker), suggest that a significant part of the new born cells in the neurogenic niche in adult human hippocampus may be glial cells.
Interpretations of our data advise against the conclusion made by Dennis et al, Sorrels et al, and
Cipriani et al (3) (4) (5) , that there is absolute post childhood seize in formation of new neurons, though we support the notion that a significant proportion of the new formed cells in the neurogenic niche may be the glial cells. We conclude that an active but minimal hippocampal neurogenesis is possibly continued in adult human.
Limitations of this study are: (i) neural tissue used for transcriptomic analysis in original data source were not exclusively taken from neurogenic niche in DG, homogenate from whole hippocampus is used, (ii) an uneven and relatively smaller sample size for some age groups, (iii) additionally, many of the neurogenesis markers we studied are known to express in more than one consecutive developmental stages, so their exact demarcation respective to the stages was not feasible. Tables (S1-2) 
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